ZLAB: Zai Lab Earnings growth forecast for next year

Graphic logo of Zai Lab Corp (ZLAB)

Zai Lab Limited (ZLAB) is optimizing costs through the outsourcing of testing and production. The market's EPS growth expectations on the precise GURU.Markets chart illustrate how 3.50 captures the magnitude of this parameter. Zai Lab Limited (ZLAB) maintains margins via cross-border logistics in Asia, although US-China trade disputes create risks of isolation from Western investments and markets.

Zai Lab Ltd (ZLAB): Projected earnings per share growth rate for next year from 07/04/2022 to 11/10/2026

zailaboratory.com (ZLAB) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Stock Price Zai Lab Ltd.|ZLAB - Broker Consensus Forecast
- market capitalization information:
Market Capitalization Zai Lab|ZLAB - Company Buyout Price
- book capitalization indicators:
Net Assets per Single Share Zai Lab|ZLAB - Accounting Capitalization|Market Capitalization to Book Value Ratio zailaboratory.com|ZLAB - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Equity Ratio Zai Lab Limited|ZLAB - Long-Term Liabilities to Equity|Short-Term Debt to Capital Zai Lab|ZLAB - Company Aggregate Debts|Debts to Book Capitalization Zai Lab|ZLAB - Long-Term Debt Volume|Company Current Liabilities Zai Lab|Quick Liquidity zailaboratory.com
- net income and valuation ratios data:
ZLAB - Company Net Income|Projected Future Earnings Zai Lab Limited|ZLAB - P/E Multiple|Forward P/E Multiple Zai Lab Limited|ZLAB - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Zai Lab|ZLAB - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Zai Lab|ZLAB - Earnings per share for the last twelve months|Quarterly EPS earnings growth zailaboratory.com|ZLAB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Zai Lab Limited
Basic company analysis:Zai Lab Ltd., ZLAB
Brand item of zailaboratory.com

Finding fundamental support in Zai Lab Limited (ZLAB) requires an analysis of the company's ability to monetize its role as the exclusive gateway for Western medicines into the Chinese market. The projected earnings per share for the coming year reflects analysts' operational reassessment of future cash flows, allowing investors to timely identify a shift in yield trends and evaluate business resilience amid Asian regulatory risks.

Competitor analysis

LLY (Eli Lilly & Co.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ABBV (AbbVie Corp.)|Earnings growth forecast for next year AZN|Consensus forecast of earnings per share growth for next year novartis.com|Net earnings per share growth forecast for next year Merck MRK|NVO: Projected earnings per share growth rate for next year|Amgen Corporation - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Pfizer Corp (PFE)|SNY (Sanofi) - Expected earnings per share growth for next year|Net earnings per share change forecast for next year BMY (bms.com)|GSK (GlaxoSmithKline plc) - Earnings growth forecast for next year|Earnings growth forecast for next year Takeda Pharmaceutical Company|Earnings growth forecast for next year TEVA|Consensus forecast of earnings per share growth for next year Dr. Reddy's Labs|Viatris Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year ROIV|BHC - Net earnings per share growth forecast for next year|COSM: Net earnings per share growth forecast for next year